Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vadhan-Raj

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanomaJ L Murray, E S Kleinerman, S F Jia, et al.
Blood|September 15, 1995
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I studyS Vadhan-Raj, H E Broxmeyer, M Andreeff, et al.
Annals of Internal Medicine|May 1, 1997
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancerS Vadhan-Raj, L J Murray, C Bueso-Ramos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2011
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndromeS Vadhan-Raj, L E Fayad, M A Fanale, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanomaJ L Murray, E S Kleinerman, S F Jia, et al.
Blood|September 15, 1995
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I studyS Vadhan-Raj, H E Broxmeyer, M Andreeff, et al.
Annals of Internal Medicine|May 1, 1997
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancerS Vadhan-Raj, L J Murray, C Bueso-Ramos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2011
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndromeS Vadhan-Raj, L E Fayad, M A Fanale, et al.
Pageof 9